Abstract
BackgroundCalcium-dependent signaling mechanisms play a critical role in platelet activation. Unlike calcium-activated protease and kinase, the contribution of calcium-activated protein serine/threonine phosphatase in platelet activation is poorly understood.
ObjectiveTo assess the role of catalytic subunit of protein phosphatase 2B (PP2B) or calcineurin in platelet function.
ResultsHere, we showed that an increase in PP2B activity was associated with agonist-induced activation of human and murine platelets. Pharmacological inhibitors of the catalytic subunit of protein phosphatase 2B (PP2B-A) such as cyclosporine A or tacrolimus (FK506) potentiated aggregation of human platelets. Murine platelets lacking the isoform of PP2B-A (PP2B-A(-/-)) displayed increased aggregation with low doses of agonist concentrations. Loss of PP2B-A did not affect agonist-induced integrin (IIb3) inside-out signaling, but increased basal Src activation and outside-in (IIb3) signaling to p38 mitogen-activated protein kinase (MAPK), with a concomitant enhancement in platelet spreading on immobilized fibrinogen and greater fibrin clot retraction. Fibrinogen-induced increased p38 activation in PP2B-A(-/-) platelets were blocked by Src inhibitor. Both PP2B-A(-/-) platelets and PP2B-A-depleted human embryonal kidney 293 (IIb3) cells displayed increased adhesion to immobilized fibrinogen. Filamin A, an actin crosslinking phosphoprotein that is known to associate with (3), was dephosphorylated on Ser(2152) in fibrinogen-adhered wild-type but not in PP2B-A(-/-) platelets. In a FeCl3 injury thrombosis model, PP2B-A(-/-) mice showed decreased time to occlusion in the carotid artery.
ConclusionThese observations indicate that PP2B-A by suppressing outside-in (IIb3) integrin signaling limits platelet response to vascular injury.